US Patent Issued to Vanda Pharmaceuticals on July 7 for "Multiple myeloma treatment" (Maryland Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,033, issued on July 7, was assigned to Vanda Pharmaceuticals Inc. (Washington).

"Multiple myeloma treatment" was invented by Mihael H. Polymeropoulos (Potomac, Md.), Louis William Licamele (Potomac, Md.) and Christian Lavedan (Potomac, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA)."

The patent was filed on June 25, 2024, under Application No. 18/754,044.

*For further informatio...